News | September 17, 2024
Wacker collaborates with MinervaX for prophylactic vaccine targeting Group B streptococcus
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Additional data from APPRAISE ATP trial reinforce modular therapy approach
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
The inspection was concluded with few procedural observations
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Subscribe To Our Newsletter & Stay Updated
